{"nctId":"NCT02452931","briefTitle":"Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty","startDateStruct":{"date":"2015-08-31","type":"ACTUAL"},"conditions":["Precocious Puberty, Central"],"count":64,"armGroups":[{"label":"Assigned Intervention","type":"EXPERIMENTAL","interventionNames":["Drug: Leuprolide Acetate 45 mg"]}],"interventions":[{"name":"Leuprolide Acetate 45 mg","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Females age 2 to 8 years (inclusive) or males age 2 to 9 years (inclusive)\n* Confirmed diagnosis of CPP within 12 months of Baseline Visit (Day 0) but have not received prior GnRH agonist treatment for CPP\n* Pubertal-type LH response following an abbreviated GnRHa stimulation test before treatment initiation\n* Clinical evidence of puberty, defined as Tanner stage ≥ 2 for breast development in females or testicular volume ≥ 4 mL in males\n* Difference between bone age (Greulich and Pyle method) and chronological age ≥ 1 year\n\nExclusion Criteria:\n\n* Gonadotropin-independent (peripheral) precocious puberty\n* Prior or current GnRH treatment for CPP\n* Prior or current therapy with medroxyprogesterone acetate, growth hormone or insulin-like growth factor-1 (IGF-1)\n* Diagnosis of short stature (ie, 2.25 standard deviations (SD) below the mean height for age)\n* Known history of seizures, epilepsy, and/or central nervous system disorders that may be associated with seizures or convulsions\n* Any other medical condition or serious intercurrent illness that, in the opinion of the Investigator, may make it undesirable for the subject to participate in the study","healthyVolunteers":false,"sex":"ALL","minimumAge":"2 Years","maximumAge":"9 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Participants With Suppression of Peak-Stimulated Luteinizing Hormone at 6 Months.","description":"Luteinizing Hormone (LH) suppression is defined as peak-stimulated LH \\<4 IU/L. Peak stimulated LH refers to the maximum LH concentration measured 30 minutes after a gonadotropin-releasing hormone agonst (GnRHa) stimulation test.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"54","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects With Suppression of Luteinizing Hormone Measured by Blood Levels.","description":"Percentage of subjects with suppressed serum LH concentrations(\\<4 IU/L) 30 minutes post GnRHa stimulation test at all assessed timepoints.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"54","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50","spread":null}]}]}]},{"type":"SECONDARY","title":"Changes in Height Velocity (Growth Rate)","description":"Changes in height velocity (growth rate) at all study timepoints after Screening to end of study. Growth velocity is defined for each visit as change from baseline / \\[(number of weeks since baseline)/52\\]. Week 48: Change from Week 24 growth velocity is defined as change from week 24 to week 48 / \\[(number of weeks since week 24)/52\\].","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.89","spread":"13.128"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.30","spread":"4.782"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.66","spread":"3.155"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.90","spread":"3.074"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.48","spread":"2.272"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.23","spread":"1.953"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.37","spread":"1.893"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.79","spread":"2.213"}]}]}]},{"type":"SECONDARY","title":"Bone Age Ratio to Chronological Age at Time of Measurement","description":"Bone Age Ratio to Chronological Age at Time of Measurement is bone age/age at bone age assessment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.39","spread":"0.160"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.34","spread":"0.138"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.32","spread":"0.143"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.30","spread":"0.138"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.36","spread":"0.138"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Height","description":"The percent change from baseline in height at each available post-baseline measurement. Percent change is defined as (((change from Baseline)/(Baseline)) x 100).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"0.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":"0.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9","spread":"0.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":"1.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.3","spread":"1.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.9","spread":"1.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.3","spread":"1.34"}]}]}]},{"type":"SECONDARY","title":"Tanner Scores: Boys - Development of External Genitalia","description":"Sexual development (physical signs) in puberty were assessed by Tanner staging, a system developed by Marshall and Tanner to categorize pubertal maturation. Tanner stages are commonly used to categorize pubertal maturation in terms of sequence, timing and tempo. Tanner Stages: the minimum is Stage 1 = pre-pubertal physical characteristics and the maximum is Stage 5 = fully matured (adult) physical characteristics.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":"0.00"}]}]}]},{"type":"SECONDARY","title":"Tanner Scores: Boys - Development of External Genitalia (Change From Baseline)","description":"Sexual development (physical signs) in puberty were assessed by Tanner staging, a system developed by Marshall and Tanner to categorize pubertal maturation. Tanner stages are commonly used to categorize pubertal maturation in terms of sequence, timing and tempo. Tanner Stages: the minimum is Stage 1 = pre-pubertal physical characteristics and the maximum is Stage 5 = fully matured (adult) physical characteristics.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.0","spread":"0.00"}]}]}]},{"type":"SECONDARY","title":"Tanner Scores: Boys and Girls - Pubic Hair","description":"Sexual development (physical signs) in puberty were assessed by Tanner staging, a system developed by Marshall and Tanner to categorize pubertal maturation. Tanner stages are commonly used to categorize pubertal maturation in terms of sequence, timing and tempo. Tanner Stages: the minimum is Stage 1 = pre-pubertal physical characteristics and the maximum is Stage 5 = fully matured (adult) physical characteristics.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":"0.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.4","spread":"0.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":"0.92"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":"0.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.4","spread":"0.95"}]}]}]},{"type":"SECONDARY","title":"Tanner Scores: Boys and Girls - Pubic Hair (Change From Baseline)","description":"Sexual development (physical signs) in puberty were assessed by Tanner staging, a system developed by Marshall and Tanner to categorize pubertal maturation. Tanner stages are commonly used to categorize pubertal maturation in terms of sequence, timing and tempo. Tanner Stages: the minimum is Stage 1 = pre-pubertal physical characteristics and the maximum is Stage 5 = fully matured (adult) physical characteristics.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1","spread":"0.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1","spread":"0.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1","spread":"0.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1","spread":"0.58"}]}]}]},{"type":"SECONDARY","title":"Tanner Scores: Girls - Breast Development","description":"Sexual development (physical signs) in puberty were assessed by Tanner staging, a system developed by Marshall and Tanner to categorize pubertal maturation. Tanner stages are commonly used to categorize pubertal maturation in terms of sequence, timing and tempo. Tanner Stages: the minimum is Stage 1 = pre-pubertal physical characteristics and the maximum is Stage 5 = fully matured (adult) physical characteristics.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.2","spread":"0.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.7","spread":"0.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.6","spread":"1.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":"0.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.4","spread":"0.93"}]}]}]},{"type":"SECONDARY","title":"Tanner Scores: Girls - Breast Development (Change From Baseline)","description":"Sexual development (physical signs) in puberty were assessed by Tanner staging, a system developed by Marshall and Tanner to categorize pubertal maturation. Tanner stages are commonly used to categorize pubertal maturation in terms of sequence, timing and tempo. Tanner Stages: the minimum is Stage 1 = pre-pubertal physical characteristics and the maximum is Stage 5 = fully matured (adult) physical characteristics.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":"0.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.6","spread":"0.87"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.6","spread":"0.86"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.7","spread":"0.89"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Height","description":"Height at each available measurement point. Baseline is defined as the last non-missing height measurement collected prior to or on the date of first injection.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"136.17","spread":"8.292"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136.61","spread":"8.071"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"137.32","spread":"8.201"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"138.52","spread":"8.284"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"138.87","spread":"8.070"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"139.78","spread":"8.206"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"140.99","spread":"8.374"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"141.81","spread":"8.268"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"142.37","spread":"8.207"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Bone Age","description":"Bone Age at each available measurement point.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11.01","spread":"1.307"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.30","spread":"1.238"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.65","spread":"1.124"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Bone Age Progression","description":"Bone age progression at each available post-baseline measurement point. Bone age progression is defined as (((change from baseline)/(baseline)) x 100), which is percent change from baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.91","spread":"4.607"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.81","spread":"5.741"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.91","spread":"4.607"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.63","spread":"5.736"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Bone Age Ratio to Chronological Age at Time of Measurement (Percent Change From Baseline)","description":"Bone Age Ratio to Chronological Age at Time of Measurement is bone age/age at bone age assessment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.25","spread":"4.382"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.90","spread":"4.689"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.15","spread":"3.934"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.89","spread":"4.155"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Bone Age Ratio to Chronological Age at Start of Study (Percent Change From Baseline)","description":"Bone age advancement was evaluated relative to chronological age at each given measurement point. Percent change from baseline is: 100 x (the change from baseline value at the post-baseline visit / baseline value).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.91","spread":"4.607"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.81","spread":"5.741"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.91","spread":"4.607"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.63","spread":"5.736"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Bone Age Ratio to Chronological Age at Start of Study","description":"Bone age advancement was evaluated relative to chronological age at each given measurement point. Bone Age Ratio to Chronological Age at Start of Study is bone age/age at first injection.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.38","spread":"0.158"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.42","spread":"0.153"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.47","spread":"0.178"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.42","spread":"0.153"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.47","spread":"0.176"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"GnRH Antagonist Evaluation","description":"GnRH Antagonist Evaluation occurred for the two week period following each treatment and at each visit to assess flare symptoms. The percent of subjects who affirm (or whose parent/guardian affirms) each symptom domain in the global interview.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null}]},{"measurements":[{"groupId":"OG000","value":"4","spread":null}]},{"measurements":[{"groupId":"OG000","value":"11","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"9","spread":null}]},{"measurements":[{"groupId":"OG000","value":"3","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"53","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"3","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"48","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"53","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null}]},{"measurements":[{"groupId":"OG000","value":"15","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"15","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"3","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"53","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"57","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Subjects With Suppression of FSH, Estradiol, Oestradiol (HS), and Testosterone Measured by Blood Levels.","description":"The percentage of subjects with FSH, estradiol and testosterone suppression to prepubertal levels (FSH \\< 2.5 mIU/mL, estradiol \\< 20 pg/mL and testosterone \\< 28.4 ng/dL) at each available time point.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"58","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"59","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"58","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"26","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"57","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Changes in the Ratio of LH/FSH","description":"Changes in ratio of LH/FSH at each time point from Screening to End of Study","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.387","spread":"0.4675"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.187","spread":"1.6713"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.604","spread":"0.9851"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.424","spread":"2.1534"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.856","spread":"1.7277"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.110","spread":"2.3939"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.542","spread":"2.0932"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.691","spread":"1.7330"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.123","spread":"1.4378"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.843","spread":"1.0004"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.233","spread":"1.1425"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.565","spread":"0.9100"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.050","spread":"1.0423"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.342","spread":"1.7934"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.721","spread":"1.7237"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.654","spread":"0.9806"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.068","spread":"1.1859"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.611","spread":"0.9571"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.007","spread":"1.1818"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.320","spread":"1.2843"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.716","spread":"1.4450"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.474","spread":"0.5249"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.125","spread":"1.0038"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.051","spread":"1.4130"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.461","spread":"15374"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.517","spread":"0.7846"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.073","spread":"1.0575"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.557","spread":"1.0957"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.033","spread":"1.2191"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.092","spread":"1.5655"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.509","spread":"1.5780"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":64},"commonTop":["Nasopharyngitis","Pyrexia","Headache","Cough","Abdominal pain"]}}}